Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group.

[1]  A. Montserrat Moliner,et al.  The European Union Policy in the Field of Rare Diseases , 2014, Public Health Genomics.

[2]  T. Płusa.  The European Medicines Agency , 2012, Cobert's Manual of Drug Safety and Pharmacovigilance.

[3]  Jianjun Gao,et al.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives. , 2012, Intractable & rare diseases research.

[4]  S. Simoens,et al.  Orphan Drugs for Rare Diseases , 2012, Drugs.

[5]  G. He,et al.  A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: Towards a made-in-China orphan drug policy , 2010, Journal of public health policy.

[6]  Helen M. Moore,et al.  Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). , 2010, Contemporary clinical trials.

[7]  黄亚明.  MedScape , 2009 .

[8]  D. Badyal.  Orphan diseases and drugs , 2006 .

[9]  M. Haffner.  Adopting orphan drugs--two dozen years of treating rare diseases. , 2006, The New England journal of medicine.

[10]  D. Taruscio,et al.  Rare diseases and orphan drugs. , 2011, Annali dell'Istituto superiore di sanita.

[11]  A. M. Moliner.  Creating a European Union framework for actions in the field of rare diseases. , 2010, Advances in experimental medicine and biology.

[12]  Peter A Merkel,et al.  Clinical research for rare disease: opportunities, challenges, and solutions. , 2009, Molecular genetics and metabolism.